Prophylactic administration of abatacept (CTLA4-1g; BMS-188667) prevents disease induction and bone destruction in a rat model of collagen-induced arthritis.

被引：0
|
作者：
Kliwinski, C [1 ]
Kukral, D [1 ]
Postelnek, J [1 ]
Krishnan, B [1 ]
Killar, L [1 ]
Nadler, S [1 ]
Townsend, R [1 ]
机构：
[1] Bristol Myers Squibb Co, Pharmaceut Res Inst, Discovery Immunol, Princeton, NJ 08543 USA
来源：
CLINICAL IMMUNOLOGY | 2005年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：S38 / S39
页数：2
相关论文
共 4 条
  • [1] Prophylactic administration of abatacept (CTLA4-Ig; BMS-188667) prevents disease induction and bone destruction in a rat model of collagen-induced arthritis
    C Kliwinski
    D Kukral
    J Postelnek
    B Krishnan
    L Killar
    S Nadler
    R Townsend
    Arthritis Research & Therapy, 7
  • [2] Prophylactic administration of abatacept (CTLA4-Ig; BMS-188667) prevents disease induction and bone destruction in a rat model of collagen-induced arthritis
    Kliwinski, C.
    Kukral, D.
    Postelnek, J.
    Krishnan, B.
    Killar, L.
    Nadler, S.
    Townsend, R.
    ARTHRITIS RESEARCH & THERAPY, 2005, 7 (Suppl 1) : S6 - S6
  • [3] Prophylactic administration of abatacept prevents disease induction and bone destruction in a rat model of collagen-induced arthritis
    Townsend, RM
    Kliwinski, C
    Kukral, D
    Postelnek, J
    Krishnan, B
    Killar, L
    Nadler, S
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 439 - 439
  • [4] Prophylactic administration of abatacept prevents disease and bone destruction in a rat model of collagen-induced arthritis
    Kliwinski, C
    Kukral, D
    Postelnek, J
    Krishnan, B
    Killar, L
    Lewin, A
    Nadler, S
    Townsend, R
    JOURNAL OF AUTOIMMUNITY, 2005, 25 (03) : 165 - 171
1